Proteomics

Dataset Information

0

Genomic and Proteomic Studies on the Mode of Action of Oxaboroles against the African Trypanosome


ABSTRACT: SCYX-7158, an oxaborole, is currently in Phase I clinical trials for the treatment of human African trypanosomiasis. Here we investigate possible modes of action against Trypanosoma brucei using a chemo-proteomic approach. SILAC-based proteomic studies using an oxaborole analogue immobilised onto a resin was used either in competition with a soluble oxaborole or an immobilised inactive control to identify thirteen proteins common to both strategies. The diverse list of binding partners from the proteomic studies suggest a degree of polypharmacology that should reduce the risk of resistance to this compound class emerging in the field.

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Trypanosoma Brucei

DISEASE(S): Trypanosomiasis

SUBMITTER: Michael Urbaniak  

LAB HEAD: Alan Fairlamb

PROVIDER: PXD002848 | Pride | 2015-11-25

REPOSITORIES: Pride

altmetric image

Publications

Genomic and Proteomic Studies on the Mode of Action of Oxaboroles against the African Trypanosome.

Jones Deuan C DC   Foth Bernardo J BJ   Urbaniak Michael D MD   Patterson Stephen S   Ong Han B HB   Berriman Matthew M   Fairlamb Alan H AH  

PLoS neglected tropical diseases 20151218 12


SCYX-7158, an oxaborole, is currently in Phase I clinical trials for the treatment of human African trypanosomiasis. Here we investigate possible modes of action against Trypanosoma brucei using orthogonal chemo-proteomic and genomic approaches. SILAC-based proteomic studies using an oxaborole analogue immobilised onto a resin was used either in competition with a soluble oxaborole or an immobilised inactive control to identify thirteen proteins common to both strategies. Cell-cycle analysis of  ...[more]

Similar Datasets

2018-05-08 | PXD002165 | Pride
2015-05-18 | E-GEOD-57621 | biostudies-arrayexpress
2015-06-15 | PXD002180 | Pride
2019-09-13 | PXD014803 | Pride
2020-03-31 | PXD016482 | Pride
2024-03-25 | PXD042022 | Pride
2024-03-25 | PXD049328 | Pride
2022-05-10 | E-MTAB-11705 | biostudies-arrayexpress
2014-07-10 | E-MTAB-1715 | biostudies-arrayexpress
2008-06-26 | E-MEXP-1533 | biostudies-arrayexpress